• Catharine Layton, Principal Scientist, Scientific Operations, Waters Corporation 
• Martin Gilar, Ph. D., Scientific Fellow, Separations R&D, Waters Corporation 
When: Wed, Jul 20, 2022 9:00 AM - 10:00 AM PDT
Event Overview: 
Non-specific binding of analytes to material surfaces is an inherent characteristic of conventional chromatographic columns and systems. This phenomenon leads to reduced sensitivity and sometimes poor peak shape of acidic molecules. In this webinar we will present a new, novel hybrid surface technology that provides a solution without the need for strong mobile phase additives, chelators, or lengthy passivation protocols. The chromatographic benefits provided when using columns and systems equipped with the MaxPeak™ High Performance Surfaces (HPS) technology will be demonstrated with antivirals, NSAIDs, cancer growth inhibitors, oligonucleotides, peptides, and glycans. 
Key Learning Objectives: 
• Understand how metal-analyte interactions can negatively impact chromatographic performance. 
• Learn how to mitigate metal-analyte interactions with the use of a novel surface technology. 
• Explore applications: antivirals, NSAIDs, cancer growth inhibitors, oligonucleotides, peptides and glycans. 
Who Should Attend: 
• Scientists who develop and/or manage UHPLC and HPLC methods in pharmaceutical laboratories. 
• Lab managers leading teams involved with the analysis of small and large molecules.